Loading...
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
BACKGROUND: Diffuse large B-cell lymphoma is a clinically and molecularly heterogeneous disease. Gene expression profiling studies have shown that the tumor microenvironment affects survival and that the angiogenesis-related signature is prognostically unfavorable. The contribution of histopathologi...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ferrata Storti Foundation
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3128218/ https://ncbi.nlm.nih.gov/pubmed/21546504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.037408 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|